Continuous Glucose Monitoring Study

Trial ID:
IRB-18-7234
Athena Philis-Tsimikas, M.D.
The MOBILE study looks to see how blood sugar is managed when using a Continuous Glucose Monitor (CGM) compared to fingerstick testing in people with Type 2 Diabetes taking long-acting insulin once or twice a day.

Inclusion Criteria

* Be 30 years old or older.
* Have been taking long-acting insulin for the last 6 months.
* Have stable medications for the last 3 months.
* Have a smartphone that works with the devices used in the study (smartphone compatibility will be assessed).
* Have diabetes managed by a primary care physician (PCP), NP, PA, etc.

Contact Info:

  • Isabel Garcia, RN
  • garcia.maria6@scrippshealth.org
  • 858-309-2602